GENEVA, March 9 -- SEAMLESS THERAPEUTICS GMBH (Tatzberg 47/4901307 Dresden) filed a patent application (PCT/EP2024/074502) for "METHOD FOR THE PRODUCTION OF A TARGET-SPECIFIC LARGE SERINE RECOMBINASE" on Sep 02, 2024. With publication no. WO/2025/046147, the details related to the patent application was published on Mar 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SCHNEIDER, Aksana (Holbeinstrasse 9601309 Dresden), LANSING, Felix (Bleichstr. 12a90429 Nurnberg)
Abstract:
The present invention pertains to a method for generating a target-specific large serine recombinase (LSR), the m...